Ogivri 150 mg powder for concentrate for solution for infusion
- Name:
Ogivri 150 mg powder for concentrate for solution for infusion
- Company:
Gerard Laboratories
- Active Ingredients:
- Legal Category:
Product subject to restricted prescription (C)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 23/03/21

Summary of Product Characteristics last updated on medicines.ie: 23/3/2021
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. Click on this link to Download PDF directly
Gerard Laboratories

Company Products
Items Per Page :
1 - 0 of 116 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 23 March 2021 SPC
Reasons for updating
- Change to section 6.3 - Shelf life
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
Legal category: Product subject to restricted prescription (C)
Updated on 23 March 2021 PIL
Reasons for updating
- Change to section 6 - date of revision
- Change to storage instructions
Updated on 7 February 2020 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to restricted prescription (C)
Updated on 7 February 2020 PIL
Reasons for updating
- New PIL for new product